I’ve specially updated the review progress of the first batch of clinically imperative overseas new drugs on Dec. 10, 2018, for details of which please refer to “Update on Review Progress of the First Batch of Clinically Imperative New Drugs: Many Drugs Approved for Marketing through Streamlined Review”. Based on this article, certain noteworthy developments recently will be updated below. (Read more on: Global Innovative Drugs Speeding up to Enter China with the Help from Policies)
